NEW DELHI: Recent report claims that Bharat Biotech is likely to commence the trials of indigenous Covaxin on children and youngsters ranging from 2 to 18 years by the end of February or early March. As per the report, the company will start the trials once it gets formal approval from the central government to conduct trials on children.